Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.
Identifieur interne : 001E07 ( PubMed/Corpus ); précédent : 001E06; suivant : 001E08Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.
Auteurs : André R. Brunoni ; Adriano H. Moffa ; Felipe Fregni ; Ulrich Palm ; Frank Padberg ; Daniel M. Blumberger ; Zafiris J. Daskalakis ; Djamila Bennabi ; Emmanuel Haffen ; Angelo Alonzo ; Colleen K. LooSource :
- The British journal of psychiatry : the journal of mental science [ 1472-1465 ] ; 2016.
English descriptors
- KwdEn :
- MESH :
- methods : Transcranial Direct Current Stimulation.
- therapy : Depressive Disorder, Major.
- Humans, Patient Outcome Assessment.
Abstract
Transcranial direct current stimulation (tDCS) is a non-pharmacological intervention for depression. It has mixed results, possibly caused by study heterogeneity.
DOI: 10.1192/bjp.bp.115.164715
PubMed: 27056623
Links to Exploration step
pubmed:27056623Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.</title><author><name sortKey="Brunoni, Andre R" sort="Brunoni, Andre R" uniqKey="Brunoni A" first="André R" last="Brunoni">André R. Brunoni</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia brunoni@usp.br.</nlm:affiliation></affiliation></author><author><name sortKey="Moffa, Adriano H" sort="Moffa, Adriano H" uniqKey="Moffa A" first="Adriano H" last="Moffa">Adriano H. Moffa</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Fregni, Felipe" sort="Fregni, Felipe" uniqKey="Fregni F" first="Felipe" last="Fregni">Felipe Fregni</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Palm, Ulrich" sort="Palm, Ulrich" uniqKey="Palm U" first="Ulrich" last="Palm">Ulrich Palm</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Padberg, Frank" sort="Padberg, Frank" uniqKey="Padberg F" first="Frank" last="Padberg">Frank Padberg</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Blumberger, Daniel M" sort="Blumberger, Daniel M" uniqKey="Blumberger D" first="Daniel M" last="Blumberger">Daniel M. Blumberger</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Daskalakis, Zafiris J" sort="Daskalakis, Zafiris J" uniqKey="Daskalakis Z" first="Zafiris J" last="Daskalakis">Zafiris J. Daskalakis</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bennabi, Djamila" sort="Bennabi, Djamila" uniqKey="Bennabi D" first="Djamila" last="Bennabi">Djamila Bennabi</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Haffen, Emmanuel" sort="Haffen, Emmanuel" uniqKey="Haffen E" first="Emmanuel" last="Haffen">Emmanuel Haffen</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Alonzo, Angelo" sort="Alonzo, Angelo" uniqKey="Alonzo A" first="Angelo" last="Alonzo">Angelo Alonzo</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Loo, Colleen K" sort="Loo, Colleen K" uniqKey="Loo C" first="Colleen K" last="Loo">Colleen K. Loo</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27056623</idno><idno type="pmid">27056623</idno><idno type="doi">10.1192/bjp.bp.115.164715</idno><idno type="wicri:Area/PubMed/Corpus">001E07</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E07</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.</title><author><name sortKey="Brunoni, Andre R" sort="Brunoni, Andre R" uniqKey="Brunoni A" first="André R" last="Brunoni">André R. Brunoni</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia brunoni@usp.br.</nlm:affiliation></affiliation></author><author><name sortKey="Moffa, Adriano H" sort="Moffa, Adriano H" uniqKey="Moffa A" first="Adriano H" last="Moffa">Adriano H. Moffa</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Fregni, Felipe" sort="Fregni, Felipe" uniqKey="Fregni F" first="Felipe" last="Fregni">Felipe Fregni</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Palm, Ulrich" sort="Palm, Ulrich" uniqKey="Palm U" first="Ulrich" last="Palm">Ulrich Palm</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Padberg, Frank" sort="Padberg, Frank" uniqKey="Padberg F" first="Frank" last="Padberg">Frank Padberg</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Blumberger, Daniel M" sort="Blumberger, Daniel M" uniqKey="Blumberger D" first="Daniel M" last="Blumberger">Daniel M. Blumberger</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Daskalakis, Zafiris J" sort="Daskalakis, Zafiris J" uniqKey="Daskalakis Z" first="Zafiris J" last="Daskalakis">Zafiris J. Daskalakis</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bennabi, Djamila" sort="Bennabi, Djamila" uniqKey="Bennabi D" first="Djamila" last="Bennabi">Djamila Bennabi</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Haffen, Emmanuel" sort="Haffen, Emmanuel" uniqKey="Haffen E" first="Emmanuel" last="Haffen">Emmanuel Haffen</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Alonzo, Angelo" sort="Alonzo, Angelo" uniqKey="Alonzo A" first="Angelo" last="Alonzo">Angelo Alonzo</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Loo, Colleen K" sort="Loo, Colleen K" uniqKey="Loo C" first="Colleen K" last="Loo">Colleen K. Loo</name><affiliation><nlm:affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The British journal of psychiatry : the journal of mental science</title><idno type="eISSN">1472-1465</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Depressive Disorder, Major (therapy)</term><term>Humans</term><term>Patient Outcome Assessment</term><term>Transcranial Direct Current Stimulation (methods)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Transcranial Direct Current Stimulation</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Depressive Disorder, Major</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Patient Outcome Assessment</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Transcranial direct current stimulation (tDCS) is a non-pharmacological intervention for depression. It has mixed results, possibly caused by study heterogeneity.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27056623</PMID><DateCreated><Year>2016</Year><Month>06</Month><Day>02</Day></DateCreated><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1472-1465</ISSN><JournalIssue CitedMedium="Internet"><Volume>208</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The British journal of psychiatry : the journal of mental science</Title><ISOAbbreviation>Br J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.</ArticleTitle><Pagination><MedlinePgn>522-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1192/bjp.bp.115.164715</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcranial direct current stimulation (tDCS) is a non-pharmacological intervention for depression. It has mixed results, possibly caused by study heterogeneity.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To assess tDCS efficacy and to explore individual response predictors.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Systematic review and individual patient data meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were gathered from six randomised sham-controlled trials, enrolling 289 patients. Active tDCS was significantly superior to sham for response (34% v. 19% respectively, odds ratio (OR) = 2.44, 95% CI 1.38-4.32, number needed to treat (NNT) = 7), remission (23.1% v. 12.7% respectively, OR = 2.38, 95% CI 1.22-4.64, NNT = 9) and depression improvement (B coefficient 0.35, 95% CI 0.12-0.57). Mixed-effects models showed that, after adjustment for other predictors and confounders, treatment-resistant depression and higher tDCS 'doses' were, respectively, negatively and positively associated with tDCS efficacy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The effect size of tDCS treatment was comparable with those reported for repetitive transcranial magnetic stimulation and antidepressant drug treatment in primary care. The most important parameters for optimisation in future trials are depression refractoriness and tDCS dose.</AbstractText><CopyrightInformation>© The Royal College of Psychiatrists 2016.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brunoni</LastName><ForeName>André R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia brunoni@usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffa</LastName><ForeName>Adriano H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fregni</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palm</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padberg</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blumberger</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daskalakis</LastName><ForeName>Zafiris J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennabi</LastName><ForeName>Djamila</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haffen</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonzo</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loo</LastName><ForeName>Colleen K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Psychiatry</MedlineTA><NlmUniqueID>0342367</NlmUniqueID><ISSNLinking>0007-1250</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007954</RefSource><PMID Version="1">19588448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neurophysiol. 2015 Jun;126(6):1185-9</RefSource><PMID Version="1">25454337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 2000 May;57(5):425-34</RefSource><PMID Version="1">10807482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuromodulation. 2014 Dec;17(8):737-42; discussion 742</RefSource><PMID Version="1">24725075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Mar 23;354(12):1231-42</RefSource><PMID Version="1">16554525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neuropsychopharmacol. 2010 Feb;13(1):61-9</RefSource><PMID Version="1">19671217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neuropsychopharmacol. 2014 Sep;17(9):1443-52</RefSource><PMID Version="1">24713139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neuropsychopharmacol. 2008 Mar;11(2):249-54</RefSource><PMID Version="1">17559710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Apr 09;8(4):e60650</RefSource><PMID Version="1">23585842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust J Physiother. 2009;55(2):129-33</RefSource><PMID Version="1">19463084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Clin Psychopharmacol. 2004 Jul;19(4):215-20</RefSource><PMID Version="1">15201568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 2013 Jan;47(1):1-7</RefSource><PMID Version="1">23084964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2009 Jul 21;6(7):e1000100</RefSource><PMID Version="1">19621070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):9-16</RefSource><PMID Version="1">22651961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neurophysiol. 2014 Feb;125(2):298-305</RefSource><PMID Version="1">23994192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2009 Sep 1;66(5):503-8</RefSource><PMID Version="1">19427633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychol Med. 2012 Sep;42(9):1791-800</RefSource><PMID Version="1">22236735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Stimul. 2012 Jul;5(3):175-95</RefSource><PMID Version="1">22037126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA Psychiatry. 2013 Apr;70(4):383-91</RefSource><PMID Version="1">23389323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2003 Sep 1;54(5):573-83</RefSource><PMID Version="1">12946886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Stimul. 2012 Jul;5(3):242-51</RefSource><PMID Version="1">21962978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neurophysiol. 2014 Nov;125(11):2150-206</RefSource><PMID Version="1">25034472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Psychiatry. 2012 Aug 17;3:74</RefSource><PMID Version="1">22912618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychiatr Dis Treat. 2014 May 07;10:727-56</RefSource><PMID Version="1">24855360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Psychiatry. 2013 Aug;28(6):356-61</RefSource><PMID Version="1">23182847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Mar 23;354(12):1243-52</RefSource><PMID Version="1">16554526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 2010 May;67(5):507-16</RefSource><PMID Version="1">20439832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Feb;5(2):e45</RefSource><PMID Version="1">18303940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Psychiatry. 2012 Jan;200(1):52-9</RefSource><PMID Version="1">22215866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2009 Jan;34(2):522-34</RefSource><PMID Version="1">18704101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychol Med. 2014 Jan;44(2):225-39</RefSource><PMID Version="1">23507264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscientist. 2011 Feb;17(1):37-53</RefSource><PMID Version="1">21343407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neuropsychopharmacol. 2006 Dec;9(6):641-54</RefSource><PMID Version="1">16939662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2012 Mar;37(4):851-64</RefSource><PMID Version="1">22169941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Depress Anxiety. 2013 Jul;30(7):646-53</RefSource><PMID Version="1">23625554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2003 Jun 18;289(23):3152-60</RefSource><PMID Version="1">12813121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Trials. 2005;2(3):209-17</RefSource><PMID Version="1">16279144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Affect Disord. 2013 Jan 25;144(3):274-8</RefSource><PMID Version="1">23146197</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063868" MajorTopicYN="Y">Patient Outcome Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065908" MajorTopicYN="N">Transcranial Direct Current Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4887722 [Available on 06/01/17]</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27056623</ArticleId><ArticleId IdType="pii">bjp.bp.115.164715</ArticleId><ArticleId IdType="doi">10.1192/bjp.bp.115.164715</ArticleId><ArticleId IdType="pmc">PMC4887722</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E07 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E07 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27056623
|texte= Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27056623" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |